迪安診斷(300244.SZ)擬收購迪會信25%股權
格隆匯 12 月 18日丨迪安診斷(300244.SZ)公佈,公司擬以2.5億元自有資金向北京執信瀚博投資管理有限公司(“北京瀚博”)收購其持有的14%廣州迪會信醫療器械有限公司(“迪會信”或“標的公司”)股權,擬以約1.96億元自有資金向廣州市執信醫療科技有限公司(“廣州執信”)收購持有的11%迪會信股權。公司此次向兩個交易對手合計收購25%的迪會信股權;此次收購完成後,加上之前公司通過合併報表範圍內的寧波梅山保税港區卓奇股權投資基金合夥企業(有限合夥)持有的22%的迪會信股權,上市公司以直接或間接方式合計持有47%的迪會信股權。
迪會信主要從事進口體外診斷產品的代理,與全球多家知名的體外診斷產品供應商緊密合作,並建立了客户信賴的業務服務網絡和綜合服務體系,為廣東省內的醫療機構提供優質體外診斷產品和高品質專業技術支持的綜合服務,其主要經銷產品覆蓋廣東省內主要大型三級、二級醫院等醫療機構,在行業內享有較高的品牌影響力和市場美譽度。此次收購迪會信股權系公司看好對廣東省廣大IVD市場的潛力和國家對粵港澳大灣區建設帶來的新發展機遇,加碼參股項目的份額,分享未來收益。
此次交易完成後,公司以直接或間接方式合計持有47%的迪會信股權,不納入公司合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.